Inotiv, Inc. (NOTV)
USD 2.03
(2.53%)
USD 2.03
(2.53%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 165.44 Million USD | 5.24% |
| 2022 | 157.21 Million USD | 421.33% |
| 2021 | 30.15 Million USD | 65.36% |
| 2020 | 18.23 Million USD | 41.14% |
| 2019 | 12.92 Million USD | 59.2% |
| 2018 | 8.11 Million USD | 5.44% |
| 2017 | 7.69 Million USD | 73.94% |
| 2016 | 4.42 Million USD | -40.91% |
| 2015 | 7.48 Million USD | -5.94% |
| 2014 | 7.96 Million USD | 12.86% |
| 2013 | 7.05 Million USD | 3.17% |
| 2012 | 6.83 Million USD | -34.91% |
| 2011 | 10.5 Million USD | 43.27% |
| 2010 | 7.33 Million USD | -3.56% |
| 2009 | 7.6 Million USD | -50.41% |
| 2008 | 15.33 Million USD | 11.17% |
| 2007 | 13.79 Million USD | -0.13% |
| 2006 | 13.8 Million USD | -10.0% |
| 2005 | 15.34 Million USD | 33.03% |
| 2004 | 11.53 Million USD | 10.8% |
| 2003 | 10.41 Million USD | -1.45% |
| 2002 | 10.56 Million USD | -12.84% |
| 2001 | 12.12 Million USD | 40.27% |
| 2000 | 8.64 Million USD | -19.25% |
| 1999 | 10.7 Million USD | 0.94% |
| 1998 | 10.6 Million USD | 16.48% |
| 1997 | 9.1 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 12.52 Million USD | -34.85% |
| 2024 Q3 | 6.96 Million USD | 68.34% |
| 2024 Q1 | 19.22 Million USD | -56.01% |
| 2023 Q2 | 44.93 Million USD | 107.21% |
| 2023 Q3 | 55.12 Million USD | 22.68% |
| 2023 Q4 | 43.7 Million USD | -20.72% |
| 2023 Q1 | 21.68 Million USD | -48.64% |
| 2023 FY | 165.44 Million USD | 5.24% |
| 2022 Q3 | 50.93 Million USD | 13.88% |
| 2022 Q1 | 19.32 Million USD | 87.48% |
| 2022 Q2 | 44.72 Million USD | 131.44% |
| 2022 FY | 157.21 Million USD | 421.33% |
| 2022 Q4 | 42.22 Million USD | -17.1% |
| 2021 Q1 | 5.87 Million USD | 27.13% |
| 2021 Q3 | 7.64 Million USD | 21.75% |
| 2021 FY | 30.15 Million USD | 65.36% |
| 2021 Q4 | 10.3 Million USD | 34.82% |
| 2021 Q2 | 6.28 Million USD | 6.86% |
| 2020 Q1 | 3.47 Million USD | -27.73% |
| 2020 Q4 | 4.62 Million USD | -6.49% |
| 2020 Q3 | 4.94 Million USD | -4.79% |
| 2020 FY | 18.23 Million USD | 41.14% |
| 2020 Q2 | 5.19 Million USD | 49.35% |
| 2019 Q1 | 2.41 Million USD | -23.69% |
| 2019 Q4 | 4.81 Million USD | 53.76% |
| 2019 FY | 12.92 Million USD | 59.2% |
| 2019 Q3 | 3.12 Million USD | 22.18% |
| 2019 Q2 | 2.56 Million USD | 5.87% |
| 2018 Q3 | 1.62 Million USD | -6.61% |
| 2018 Q1 | 1.58 Million USD | -15.18% |
| 2018 FY | 8.11 Million USD | 5.44% |
| 2018 Q4 | 3.17 Million USD | 95.08% |
| 2018 Q2 | 1.74 Million USD | 10.06% |
| 2017 Q3 | 1.93 Million USD | -5.48% |
| 2017 Q1 | 1.85 Million USD | 95.27% |
| 2017 FY | 7.69 Million USD | 73.94% |
| 2017 Q2 | 2.04 Million USD | 9.9% |
| 2017 Q4 | 1.86 Million USD | -3.47% |
| 2016 FY | 4.42 Million USD | -40.91% |
| 2016 Q2 | 1.31 Million USD | 33.74% |
| 2016 Q1 | 984 Thousand USD | -23.9% |
| 2016 Q3 | 1.17 Million USD | -10.87% |
| 2016 Q4 | 952 Thousand USD | -18.84% |
| 2015 Q1 | 1.9 Million USD | 4.56% |
| 2015 Q2 | 1.8 Million USD | -5.36% |
| 2015 Q3 | 2.49 Million USD | 38.18% |
| 2015 Q4 | 1.29 Million USD | -48.07% |
| 2015 FY | 7.48 Million USD | -5.94% |
| 2014 FY | 7.96 Million USD | 12.86% |
| 2014 Q4 | 1.82 Million USD | -8.22% |
| 2014 Q3 | 1.98 Million USD | -1.39% |
| 2014 Q2 | 2.01 Million USD | -6.2% |
| 2014 Q1 | 2.14 Million USD | 12.36% |
| 2013 FY | 7.05 Million USD | 3.17% |
| 2013 Q4 | 1.9 Million USD | -6.05% |
| 2013 Q3 | 2.03 Million USD | 61.53% |
| 2013 Q2 | 1.25 Million USD | -32.18% |
| 2013 Q1 | 1.85 Million USD | -13.88% |
| 2012 Q1 | 1.48 Million USD | -34.07% |
| 2012 Q3 | 2.05 Million USD | 80.14% |
| 2012 FY | 6.83 Million USD | -34.91% |
| 2012 Q2 | 1.14 Million USD | -22.87% |
| 2012 Q4 | 2.15 Million USD | 4.61% |
| 2011 Q2 | 2.79 Million USD | 2.98% |
| 2011 Q4 | 2.24 Million USD | -18.11% |
| 2011 Q1 | 2.71 Million USD | 37.1% |
| 2011 FY | 10.5 Million USD | 43.27% |
| 2011 Q3 | 2.74 Million USD | -1.86% |
| 2010 Q1 | 1.19 Million USD | -53.1% |
| 2010 Q2 | 1.48 Million USD | 24.16% |
| 2010 Q3 | 2.67 Million USD | 79.87% |
| 2010 FY | 7.33 Million USD | -3.56% |
| 2010 Q4 | 1.98 Million USD | -25.83% |
| 2009 Q4 | 2.55 Million USD | 19.44% |
| 2009 FY | 7.6 Million USD | -50.41% |
| 2009 Q1 | 2.04 Million USD | -31.12% |
| 2009 Q2 | 872 Thousand USD | -57.4% |
| 2009 Q3 | 2.13 Million USD | 144.84% |
| 2008 Q3 | 4.31 Million USD | 26.2% |
| 2008 Q4 | 2.97 Million USD | -31.14% |
| 2008 Q1 | 3.5 Million USD | 12.96% |
| 2008 Q2 | 3.42 Million USD | -2.43% |
| 2008 FY | 15.33 Million USD | 11.17% |
| 2007 Q2 | 3.18 Million USD | -6.06% |
| 2007 Q4 | 3.1 Million USD | -24.65% |
| 2007 Q3 | 4.11 Million USD | 29.5% |
| 2007 FY | 13.79 Million USD | -0.13% |
| 2007 Q1 | 3.38 Million USD | 5.75% |
| 2006 Q1 | 3.14 Million USD | -23.83% |
| 2006 Q2 | 4.93 Million USD | 56.83% |
| 2006 Q3 | 2.53 Million USD | -48.72% |
| 2006 Q4 | 3.2 Million USD | 26.52% |
| 2006 FY | 13.8 Million USD | -10.0% |
| 2005 Q1 | 3.62 Million USD | 46.78% |
| 2005 Q2 | 2.42 Million USD | -33.11% |
| 2005 Q3 | 5.02 Million USD | 107.17% |
| 2005 Q4 | 4.13 Million USD | -17.83% |
| 2005 FY | 15.34 Million USD | 33.03% |
| 2004 Q3 | 4.22 Million USD | 91.65% |
| 2004 Q1 | 2.63 Million USD | 13.76% |
| 2004 FY | 11.53 Million USD | 10.8% |
| 2004 Q4 | 2.47 Million USD | -41.5% |
| 2004 Q2 | 2.2 Million USD | -16.36% |
| 2003 Q2 | 2.25 Million USD | -15.94% |
| 2003 Q1 | 2.68 Million USD | 13.35% |
| 2003 FY | 10.41 Million USD | -1.45% |
| 2003 Q4 | 2.31 Million USD | -26.52% |
| 2003 Q3 | 3.15 Million USD | 39.65% |
| 2002 Q3 | 2.49 Million USD | -20.81% |
| 2002 Q4 | 2.36 Million USD | -4.95% |
| 2002 FY | 10.56 Million USD | -12.84% |
| 2002 Q2 | 3.14 Million USD | 23.12% |
| 2002 Q1 | 2.55 Million USD | -18.24% |
| 2001 Q4 | 3.12 Million USD | 0.84% |
| 2001 FY | 12.12 Million USD | 40.27% |
| 2001 Q3 | 3.1 Million USD | -10.71% |
| 2001 Q2 | 3.47 Million USD | 21.31% |
| 2001 Q1 | 2.86 Million USD | 2.97% |
| 2000 Q4 | 2.77 Million USD | 12.35% |
| 2000 Q2 | 1.67 Million USD | -1.29% |
| 2000 Q1 | 1.7 Million USD | -43.33% |
| 2000 Q3 | 2.47 Million USD | 47.44% |
| 2000 FY | 8.64 Million USD | -19.25% |
| 1999 Q3 | 2.6 Million USD | -7.14% |
| 1999 Q2 | 2.8 Million USD | 16.67% |
| 1999 Q1 | 2.4 Million USD | -7.69% |
| 1999 FY | 10.7 Million USD | 0.94% |
| 1999 Q4 | 3 Million USD | 15.38% |
| 1998 Q4 | 2.6 Million USD | 0.0% |
| 1998 Q1 | 2.7 Million USD | 33.66% |
| 1998 Q2 | 2.8 Million USD | 3.7% |
| 1998 FY | 10.6 Million USD | 16.48% |
| 1998 Q3 | 2.6 Million USD | -7.14% |
| 1997 FY | 9.1 Million USD | 0.0% |
| 1997 Q4 | 2.02 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -1156.402% |
| Biodesix, Inc. | 36.07 Million USD | -358.583% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -20799.427% |
| Castle Biosciences, Inc. | 174.8 Million USD | 5.356% |
| DarioHealth Corp. | 5.98 Million USD | -2664.756% |
| Exact Sciences Corporation | 1.84 Billion USD | 91.035% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 92.445% |
| Illumina, Inc. | 2.74 Billion USD | 93.971% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -11504.937% |
| iSpecimen Inc. | 5.1 Million USD | -3138.953% |
| Standard BioTools Inc. | 50.45 Million USD | -227.935% |
| 23andMe Holding Co. | 99.37 Million USD | -66.48% |
| Medpace Holdings, Inc. | 524.5 Million USD | 68.457% |
| NeoGenomics, Inc. | 244.6 Million USD | 32.363% |
| Psychemedics Corporation | 8.41 Million USD | -1866.516% |
| Prenetics Global Limited | 8.82 Million USD | -1773.671% |
| Precipio, Inc. | 6.01 Million USD | -2649.136% |
| RadNet, Inc. | 93 Million USD | -77.896% |
| Sotera Health Company | 577.15 Million USD | 71.335% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -1287.246% |
| Exagen Inc. | 29.45 Million USD | -461.661% |
| Natera, Inc. | 492.74 Million USD | 66.424% |
| Aspira Women's Health Inc. | 5.26 Million USD | -3044.109% |
| Neogen Corporation | 463.9 Million USD | 64.336% |
| Myriad Genetics, Inc. | 476.4 Million USD | 65.272% |
| ICON Public Limited Company | 1.81 Billion USD | 90.881% |
| Bionano Genomics, Inc. | 9.56 Million USD | -1629.49% |
| CareDx, Inc | 178.32 Million USD | 7.224% |
| Check-Cap Ltd. | -212 Thousand USD | 78139.151% |
| Twist Bioscience Corporation | 133.34 Million USD | -24.068% |
| Guardant Health, Inc. | 336.89 Million USD | 50.892% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -12344.02% |
| Fulgent Genetics, Inc. | 104.45 Million USD | -58.385% |
| Sera Prognostics, Inc. | 96 Thousand USD | -172236.458% |
| OPKO Health, Inc. | 318.12 Million USD | 47.995% |
| Personalis, Inc. | 18.2 Million USD | -808.628% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -2889.88% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -1287.246% |
| MDxHealth SA | 43.92 Million USD | -276.615% |
| Prenetics Global Limited | 8.82 Million USD | -1773.671% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 60162.588% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -32361.509% |
| Trinity Biotech plc | 19.45 Million USD | -750.607% |
| Neuronetics, Inc. | 51.7 Million USD | -219.975% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -20799.427% |